No CrossRef data available.
Article contents
Improving High-Risk Patient Care through Chronic Disease Prevention and Management
Published online by Cambridge University Press: 01 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Independent Articles: Commentary
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2018
References
McWilliams, J.M. and Schwartz, A.L., “Focusing on High-Cost Patients — The Key to Addressing High Costs?” New England Journal of Medicine 376 (2017): 807-809.CrossRefGoogle Scholar
Cynamon, J.K., “Normative Concerns with High-Risk Pools,” Journal of Law, Medicine & Ethics 46, no. 3 (2018): 766-772.CrossRefGoogle Scholar
See McWilliams, supra note 1.Google Scholar
Hwang, W., LaClair, M., Camacho, F., and Paz, H., “Persistent High Utilization in a Privately Insured Population,” The American Journal of Managed Care 21 (2015): 309-316.Google Scholar
See McWilliams, supra note 1.Google Scholar
Pringle, J.L., Boyer, A., Conklin, M.H., McCullough, J.W. and Aldridge, A., “The Pennsylvania Project: Pharmacist Intervention Improved Medication Adherence and Reduced Health Care Costs,” Health Affairs 33 (2014): 1444-1452.Google Scholar
Schurrer, J., O'Malley, A., Wilson, C., McCall, N., and Jain, N., “Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report, 50131” (November 2, 2017).Google Scholar
Porter, M.E., Kramer, M.R. and Sesia, A., “Discovery Limited,” Harvard Business School Case 715-423 (2014): 1-18.Google Scholar